|Articles|April 1, 2017
- Pharmaceutical Executive-04-01-2017
- Volume 37
- Issue 4
Pharmaceutical Executive, April 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
HBA's Woman of the Year 2017over 8 years ago
Sales Force Effectiveness, Millennial Styleover 8 years ago
The Lengthening Arm of Pharmacovigilanceover 8 years ago
When Rare Becomes Commonover 8 years ago
Advancing Rare Disease R&D: A Mission Updateover 8 years ago
A Faster, More Flexible, and Frugal FDA?over 8 years ago
Country Report: GreeceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
